Logo image of BN.PA

DANONE (BN.PA) Stock Fundamental Analysis

Europe - EPA:BN - FR0000120644 - Common Stock

73.76 EUR
+0.28 (+0.38%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BN. BN was compared to 58 industry peers in the Food Products industry. BN has an excellent profitability rating, but there are some minor concerns on its financial health. BN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BN was profitable.
In the past year BN had a positive cash flow from operations.
In the past 5 years BN has always been profitable.
Each year in the past 5 years BN had a positive operating cash flow.
BN.PA Yearly Net Income VS EBIT VS OCF VS FCFBN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

BN's Return On Assets of 4.20% is fine compared to the rest of the industry. BN outperforms 60.34% of its industry peers.
BN has a Return On Equity of 11.59%. This is in the better half of the industry: BN outperforms 65.52% of its industry peers.
BN's Return On Invested Capital of 6.83% is fine compared to the rest of the industry. BN outperforms 63.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BN is in line with the industry average of 7.05%.
The last Return On Invested Capital (6.83%) for BN is above the 3 year average (6.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.2%
ROE 11.59%
ROIC 6.83%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
BN.PA Yearly ROA, ROE, ROICBN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 6.72%, BN is doing good in the industry, outperforming 72.41% of the companies in the same industry.
In the last couple of years the Profit Margin of BN has remained more or less at the same level.
BN has a better Operating Margin (13.25%) than 77.59% of its industry peers.
BN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 50.47%, BN is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
BN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.25%
PM (TTM) 6.72%
GM 50.47%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
BN.PA Yearly Profit, Operating, Gross MarginsBN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BN is still creating some value.
BN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BN has less shares outstanding
The debt/assets ratio for BN has been reduced compared to a year ago.
BN.PA Yearly Shares OutstandingBN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BN.PA Yearly Total Debt VS Total AssetsBN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.49 indicates that BN is not a great score, but indicates only limited risk for bankruptcy at the moment.
BN has a Altman-Z score of 2.49. This is in the better half of the industry: BN outperforms 62.07% of its industry peers.
BN has a debt to FCF ratio of 5.07. This is a neutral value as BN would need 5.07 years to pay back of all of its debts.
BN has a better Debt to FCF ratio (5.07) than 65.52% of its industry peers.
A Debt/Equity ratio of 0.83 indicates that BN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.83, BN is not doing good in the industry: 65.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.07
Altman-Z 2.49
ROIC/WACC1.09
WACC6.24%
BN.PA Yearly LT Debt VS Equity VS FCFBN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

BN has a Current Ratio of 0.95. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BN (0.95) is worse than 75.86% of its industry peers.
BN has a Quick Ratio of 0.95. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BN (0.78) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.78
BN.PA Yearly Current Assets VS Current LiabilitesBN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.47% over the past year.
The Earnings Per Share has been decreasing by -1.17% on average over the past years.
Looking at the last year, BN shows a small growth in Revenue. The Revenue has grown by 0.54% in the last year.
The Revenue has been growing slightly by 1.60% on average over the past years.
EPS 1Y (TTM)4.47%
EPS 3Y3.12%
EPS 5Y-1.17%
EPS Q2Q%6.11%
Revenue 1Y (TTM)0.54%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%-0.15%

3.2 Future

BN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.54% yearly.
The Revenue is expected to grow by 3.03% on average over the next years.
EPS Next Y7.14%
EPS Next 2Y6.65%
EPS Next 3Y7.05%
EPS Next 5Y5.54%
Revenue Next Year0.87%
Revenue Next 2Y1.88%
Revenue Next 3Y2.55%
Revenue Next 5Y3.03%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BN.PA Yearly Revenue VS EstimatesBN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B
BN.PA Yearly EPS VS EstimatesBN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.72, the valuation of BN can be described as rather expensive.
BN's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of BN to the average of the S&P500 Index (27.38), we can say BN is valued slightly cheaper.
With a Price/Forward Earnings ratio of 17.86, BN is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BN is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of BN to the average of the S&P500 Index (22.86), we can say BN is valued slightly cheaper.
Industry RankSector Rank
PE 19.72
Fwd PE 17.86
BN.PA Price Earnings VS Forward Price EarningsBN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BN.
The rest of the industry has a similar Price/Free Cash Flow ratio as BN.
Industry RankSector Rank
P/FCF 17.52
EV/EBITDA 10.56
BN.PA Per share dataBN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of BN may justify a higher PE ratio.
PEG (NY)2.76
PEG (5Y)N/A
EPS Next 2Y6.65%
EPS Next 3Y7.05%

5

5. Dividend

5.1 Amount

BN has a Yearly Dividend Yield of 2.87%. Purely for dividend investing, there may be better candidates out there.
BN's Dividend Yield is a higher than the industry average which is at 3.27.
BN's Dividend Yield is a higher than the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.87%

5.2 History

The dividend of BN has a limited annual growth rate of 1.58%.
Dividend Growth(5Y)1.58%
Div Incr Years3
Div Non Decr Years4
BN.PA Yearly Dividends per shareBN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

BN pays out 74.99% of its income as dividend. This is not a sustainable payout ratio.
The dividend of BN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP74.99%
EPS Next 2Y6.65%
EPS Next 3Y7.05%
BN.PA Yearly Income VS Free CF VS DividendBN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
BN.PA Dividend Payout.BN.PA Dividend Payout, showing the Payout Ratio.BN.PA Dividend Payout.PayoutRetained Earnings

DANONE

EPA:BN (9/19/2025, 7:00:00 PM)

73.76

+0.28 (+0.38%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-30 2025-07-30/dmh
Earnings (Next)10-07 2025-10-07
Inst Owners48.65%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap50.26B
Analysts72.26
Price Target77.34 (4.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.87%
Yearly Dividend2.1
Dividend Growth(5Y)1.58%
DP74.99%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.19%
PT rev (3m)2.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.76%
EPS NY rev (3m)-0.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-0.87%
Valuation
Industry RankSector Rank
PE 19.72
Fwd PE 17.86
P/S 1.84
P/FCF 17.52
P/OCF 13.07
P/B 3.17
P/tB N/A
EV/EBITDA 10.56
EPS(TTM)3.74
EY5.07%
EPS(NY)4.13
Fwd EY5.6%
FCF(TTM)4.21
FCFY5.71%
OCF(TTM)5.64
OCFY7.65%
SpS40.15
BVpS23.28
TBVpS-9.5
PEG (NY)2.76
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.2%
ROE 11.59%
ROCE 12.02%
ROIC 6.83%
ROICexc 8.36%
ROICexgc 50.58%
OM 13.25%
PM (TTM) 6.72%
GM 50.47%
FCFM 10.49%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
ROICexc(3y)7.67%
ROICexc(5y)7.39%
ROICexgc(3y)52.44%
ROICexgc(5y)45.6%
ROCE(3y)10.98%
ROCE(5y)10.58%
ROICexcg growth 3Y19.7%
ROICexcg growth 5Y13.36%
ROICexc growth 3Y4.65%
ROICexc growth 5Y1.26%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.07
Debt/EBITDA 2.71
Cap/Depr 77.72%
Cap/Sales 3.57%
Interest Coverage 23.53
Cash Conversion 78.8%
Profit Quality 156.01%
Current Ratio 0.95
Quick Ratio 0.78
Altman-Z 2.49
F-Score8
WACC6.24%
ROIC/WACC1.09
Cap/Depr(3y)59.49%
Cap/Depr(5y)65.43%
Cap/Sales(3y)3.2%
Cap/Sales(5y)3.59%
Profit Quality(3y)220.86%
Profit Quality(5y)178.79%
High Growth Momentum
Growth
EPS 1Y (TTM)4.47%
EPS 3Y3.12%
EPS 5Y-1.17%
EPS Q2Q%6.11%
EPS Next Y7.14%
EPS Next 2Y6.65%
EPS Next 3Y7.05%
EPS Next 5Y5.54%
Revenue 1Y (TTM)0.54%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%-0.15%
Revenue Next Year0.87%
Revenue Next 2Y1.88%
Revenue Next 3Y2.55%
Revenue Next 5Y3.03%
EBIT growth 1Y3.81%
EBIT growth 3Y2.2%
EBIT growth 5Y-1.53%
EBIT Next Year35.65%
EBIT Next 3Y14.25%
EBIT Next 5Y9.9%
FCF growth 1Y12.42%
FCF growth 3Y6.14%
FCF growth 5Y3.12%
OCF growth 1Y12.55%
OCF growth 3Y3.31%
OCF growth 5Y2.15%